Citation

Farrugia A, Fraser S, Dwyer R. Contemp. Drug Probl. 2017; 44(3): 163-175.

Copyright

(Copyright © 2017, SAGE Publishing)

DOI

10.1177/0091450917723350

PMID

unavailable

Abstract

This commentary explores the complex position that take-home naloxone holds as a harm reduction strategy in contemporary public health contexts. Providing the opioid antagonist naloxone to people who consume opioids and others likely to witness opioid overdose is currently positioned as an exemplary lifesaving public health intervention. Few socially oriented studies of take-home naloxone raise questions beyond whether or not take-home naloxone "works"--lines of inquiry that we think should be raised. Until take-home naloxone efforts address harms as effects of social context and policy regimes, the focus on individual behavior change will constrain the equitable distribution of responsibility for tackling overdose and the capacity to achieve more ambitious harm reduction goals such as decriminalization and the associated destigmatization of those who consume opioids. We conclude by arguing for the analytic incorporation of issues of power and normalization that animate responses to opioid overdose, including take-home naloxone.

Keywords take-home naloxone, opioid consumption, opioid overdose, harm reduction, politics

Language: en